Effect of donor-specific transfusion in combination with FK 506 in rat cardiac allotransplantation.

[1]  M. Drayson,et al.  Donor-specific blood transfusion does not enhance the effect of FTY720 in rat cardiac allotransplantation. , 1998, Transplantation proceedings.

[2]  P. Mcmaster,et al.  Combination treatment effectively intercepts advanced acute cardiac rejection. , 1997, Transplantation proceedings.

[3]  D Talbot,et al.  Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. , 1997, Transplantation.

[4]  R. Guttmann,et al.  The effect of transfusion with donor-specific peripheral lymphocytes, whole blood or erythrocytes on cardiac allograft survival in cyclosporine-treated rats. , 1994, Transplantation.

[5]  G. Gollin,et al.  Prolongation of allograft survival in rat heterotopic heart transplantation by TLCK, a serine protease inhibitor. , 1994, Transplantation.

[6]  M. Okuhara,et al.  FK 506: historical perspectives. , 1991, Transplantation proceedings.

[7]  J. Alexander,et al.  Enhancement of allograft survival by donor-specific transfusion one day prior to transplant. Importance of timing and specificity when DST is given with cyclosporine. , 1991, Transplantation.

[8]  J. Bradley The blood transfusion effect: experimental aspects. , 1991, Immunology letters.

[9]  C. Pouteil‐Noble,et al.  The value of platelet transfusions as preparation for kidney transplantation. , 1991, Transplantation.

[10]  K. Reemtsma,et al.  INDUCTION OF DONOR‐SPECIFIC UNRESPONSIVENESS TO RAT CARDIAC ALLOGRAFT BY DONOR LEUKOCYTES AND CYCLOSPORINE , 1988, Transplantation.

[11]  K. Wood,et al.  PRODUCTION OF INDEFINITE RENAL ALLOGRAFT SURVIVAL IN THE RAT BY PRETREATMENT WITH VIABLE AND NONVIABLE HEPATOCYTES OR LIVER MEMBRANE EXTRACTS1 , 1988, Transplantation.

[12]  K. Isono,et al.  STUDIES OF THE EFFECTS OF FK506 ON RENAL ALLOGRAFTING IN THE BEAGLE DOG , 1987, Transplantation.

[13]  Masashi Hashimoto,et al.  Structure of FK506, a novel immunosuppressant isolated from Streptomyces , 1987 .

[14]  K. Wood,et al.  Pretreatment with lymphocyte subpopulations and renal allograft survival in the rat. , 1987, Transplantation.

[15]  Wood Ra,et al.  Pregraft allogeneic platelets are comparable with pregraft blood in prolonging the survival of rat renal allografts. , 1985 .

[16]  H. Schanzer,et al.  Long-term prolongation of cardiac allografts by subtherapeutic levels of cyclosporine in rats conditioned with pretransplant blood transfusions and cyclosporine. , 1985, Transplantation.

[17]  K. Wood,et al.  Suppression of renal allograft rejection in the rat by class I antigens on purified erythrocytes. , 1985, Transplantation.

[18]  Z. Varghese,et al.  THE ENHANCING AND SENSITIZING EFFECTS OF DONOR BLOOD COMPONENTS, INCLUDING DENDRITIC CELLS, IN A RAT RENAL ALLOGRAFT MODEL , 1984, Transplantation.

[19]  B. Kahan,et al.  Prolongation of rat kidney allografts by pretransplant administration of donor antigen extract or whole blood transfusion combined with a short course of cyclosporine. , 1983, Transplantation.

[20]  R. Stoney,et al.  Deliberate Donor‐specific Blood Transfusions Prior to Living Related Renal Transplantation: A New Approach , 1980, Annals of surgery.

[21]  D. Davies,et al.  Only B lymphocytes induce active enhancement of rat cardiac allografts. , 1980, Transplantation.

[22]  P. Terasaki,et al.  Improvement of kidney-graft survival with increased numbers of blood transfusions. , 1978, The New England journal of medicine.

[23]  M. R. Mickey,et al.  Effect of blood transfusions on subsequent kidney transplants. , 1973, Transplantation proceedings.

[24]  P. Morris,et al.  THE EFFECT OF DONOR STRAIN BLOOD PRETREATMENT ON RENAL ALLOGRAFT REJECTION IN RATS , 1972, Transplantation.

[25]  P. Medawar,et al.  ‘Actively Acquired Tolerance’ of Foreign Cells , 1953, Nature.